Manuel Aivado - Mar 22, 2022 Form 4 Insider Report for AILERON THERAPEUTICS INC (ALRN)

Role
President and Chief Executive Officer, Director
Signature
/s/ Richard Wanstall, attorney in fact for Manuel Aivado
Stock symbol
ALRN
Transactions as of
Mar 22, 2022
Transactions value $
$0
Form type
4
Date filed
3/24/2022, 07:44 PM
Previous filing
Jun 17, 2021
Next filing
Mar 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +1.13M $0.00 1.13M Mar 22, 2022 Common Stock 1.13M $0.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 22, 2022. The shares underlying the option are scheduled to vest in equal monthly installments through March 22, 2026.

Remarks:

President and Chief Executive Officer